First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial
We have improved our eMediNexus Platform with a far superior user experience.
Please click here to try it
Editor-in-Chief eMediNexus – Dr KK Aggarwal
24th July 2018
Woman dies during surgery, family alleges negligence: No surgery is risk free.

Dr KK Aggarwal, Recipient of Padma Shri

A 50-year-old woman died during a kidney operation at a private hospital in Patiala here on Sunday morning. Members of the deceased’s family have alleged negligence. However, doctors said the patient had died due to the cardiac arrest. The deceased, Shanti Devi, was admitted to Janak Surgicare and Ankur Advanced Urology Centre for bilateral kidney ailment on July 12. Shanti Devi, a resident of Ulaana village near Ghanaur in Patiala, was earlier operated for kidney stone on July 13 and July 14. However, she died during another operation on Sunday morning, said the police. Doctor Ankur Bansal from the hospital said: "The patient was suffering from bilateral kidney ailment. She was operated on July 13 and July 14. However, when we were operating for the third time on Sunday morning, the patient died during operation due to a cardiac arrest after anaesthesia. (TOI, Tribune)

Overall anesthesia-related mortality rates vary from two deaths per 10,000 anesthetics administered to one death per 200,000 anesthetics. Standard American Society of Anesthesiologists (ASA) monitors include pulse oximetry, electrocardiography (ECG), a noninvasive blood pressure device, and temperature, as well as integrated monitors on all anesthesia machines that generate alarms for common and/or serious potential problems....read more

Top News

Progress is slowing and time is running out to reach the 2020 HIV targets, cautions UNAIDS

UNAIDS has issued a wake-up call. In a new report "Miles to go-closing gaps, breaking barriers, righting injustices", launched in Paris, France at an event co-hosted with Coalition PLUS, UNAIDS warns that the global response to HIV is at a precarious point. At the halfway point to the .... read more


List of new drugs approved by CDSCO from 1.1.2018

Name of drug:Apremilast bulk & Apremilast 10mg, 20mg, 30mg - film coated tablets Indication/s:Indicated for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy Date of issue: 25.06.2018 .... read more

Morning Medtalks

Morning MEDTalks with Dr KK Aggarwal 24th July 2018

Around the globe - The National Longitudinal Lesbian Family Study (NLLFS) followed a group of lesbian parents since they first planned for kids in the late 1980s and early 1990s. Those children are about 25 years old now. According to the study, published in the New England Journal of Medicine, they’re doing perfectly fine. .. read more

Practice Updates

Some common food additives may pose health risks to children, says AAP

A new American Academy of Pediatrics (AAP) policy statement "Food Additives and Child Health" published online July 23 in Pediatrics has called for urgently needed reforms to the US food additive regulatory process. Some additives are put directly in foods, while "indirect" additives ... read more


Fractures increase mortality risk in the elderly

According to a study published July 19, 2018 in the Journal of Clinical Endocrinology & Metabolism, fractures in the elderly increase the risk of death for up to 10 years after the event. Mortality risk was 33% higher in men and 20% higher in women at one year after the fracture. For ... read more


Epinephrine shown to improve survival in out-of-hospital cardiac arrest

Use of epinephrine during resuscitation for out-of-hospital cardiac arrest significantly improved 30-day survival compared to placebo in a study reported in the New England Journal of Medicine online July 18, 2018. Patients in the epinephrine group had a higher rate of return of spontaneous .... read more


A new single dose drug for malaria

The US FDA has approved Krintafel (tafenoquine), a new single dose (300 mg antimalarial drug. It is indicated for the radical cure (prevention of relapse) of Plasmodium vivax malaria in patients aged 16 years and older who are receiving appropriate antimalarial therapy for acute P. vivax infection. Tafenoquine is not indicated for the treatment of acute P. vivax malaria. FDA has advised testing for glucose-6-phosphate dehydrogenase (G6PD) deficiency and pregnancy test .... read more


SENIOR trial demonstrates efficacy of insulin glargine 300 in older adults with type 2 diabetes

Results from the SENIOR trial published in the August 2018 issue of the journal Diabetes Care demonstrate the efficacy and safety of insulin glargine 300 Units/mL in adults aged 65 years and older with type 2 diabetes compared to insulin glargine 100 Units/mL. Comparable reductions in .... read more


Alzheimer's Association releases new Alzheimer’s disease guidelines for primary care physicians

The Alzheimer's Association presented its first-ever clinical practice guidelines with 20 recommendations for primary care physicians for evaluation of Alzheimer's disease, dementia, and neurodegenerative cognitive behavioral syndromes at Alzheimer's Association International.... read more


eMedi Humor
Medicolegal Corner
eMedi Quiz
1. Rotavirus infection.
2. Enterotoxigenic E. coli infection
3. Staphylococcal toxin.
4. Clostridium perfringens infection.
Lifestyle Updates
 
Inspirational Story 1: The Three Races
Inspirational Story 2: A Violin with Three Strings
Fluoroquinolones should only be prescribed in certain medical conditions
Indiscriminate use of antibiotics contributing to resistance over time
 
New Delhi, 23rd July 2018: As per a new study, in medical offices and emergency departments, about 5% of all fluoroquinolones prescribed for adults are completely unnecessary. About 20% of all fluoroquinolone prescriptions do not adhere to recommendations about their use as a first-line therapy. The study also indicates that fluoroquinolones are commonly prescribed for conditions when antibiotics are not needed at all.

Based on the FDA's warning, fluoroquinolones should only be used in patients with acute bacterial sinusitis and bacterial exacerbation of chronic bronchitis, or uncomplicated urinary tract infections in the absence of other treatment options. Prescribing the right antibiotic, at the right dose, for the right duration, and at the right time helps optimize patient care and fight antibiotic resistance.

To Read More or Comment, Click Here